Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Treatment of early stage adenocarcinoma

Share :

Choosing Wisely: Value added cancer care for India

15 - 16 Oct 2019
Published: 20 Feb 2020
Views: 782
Rating:
Save
Dr C S Pramesh - Tata Memorial Hospital, Mumbai, India

Prof C S Pramesh presents a talk on 'Treatment of early stage adenocarcinoma' at the Choosing wisely: Value Added Cancer Care for India event in New Delhi.

Related Videos

Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC ( Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA )
17 Oct 2023
OncoAlert Round Up for September 15-21, 2023
Dr Gil Morgan - Executive Director, OncoAlert
OncoAlert Round Up for September 15-21, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )
25 Sep 2023
OncoAlert Round Up for August 4th - 10th, 2023
Dr Gil Morgan - Executive Director, OncoAlert
OncoAlert Round Up for August 4th - 10th, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )
14 Aug 2023
Time toxicity: the burden on cancer patients
Dr Arjun Gupta - University of Minnesota, Minneapolis, USA
Time toxicity: the burden on cancer patients ( Dr Arjun Gupta - University of Minnesota, Minneapolis, USA )
24 May 2023
Choosing Wisely in radiology Tanzania
Dr Revelian Iramu - Ocean Road Cancer Institute, Dar es Salaam, Tanzania
Choosing Wisely in radiology Tanzania ( Dr Revelian Iramu - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )
18 May 2023
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast...
Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German )
2 May 2023
Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity...
Dr Luis Paz-Ares - Hospital Universitario 12 de Octubre, Madrid, Spain
Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity for patients with nonsquamous NSCLC ( Dr Luis Paz-Ares - Hospital Universitario 12 de Octubre, Madrid, Spain )
26 Apr 2023
VT3989 is safe and well tolerated in patients with advanced malignant...
Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA
VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA )
25 Apr 2023
To avoid unnecessary second surgery in differentiated thyroid cancer
Dr Thou Sarameth - Calmette Hospital, Phnom Penh, Cambodia
To avoid unnecessary second surgery in differentiated thyroid cancer ( Dr Thou Sarameth - Calmette Hospital, Phnom Penh, Cambodia )
25 Apr 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation